GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Chase Sun Pharmaceutical Co Ltd (SZSE:300026) » Definitions » Price-to-Operating-Cash-Flow

Tianjin Chase Sun Pharmaceutical Co (SZSE:300026) Price-to-Operating-Cash-Flow : 7.43 (As of Jun. 19, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Tianjin Chase Sun Pharmaceutical Co Price-to-Operating-Cash-Flow?

As of today (2024-06-19), Tianjin Chase Sun Pharmaceutical Co's share price is ¥3.21. Tianjin Chase Sun Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.43. Hence, Tianjin Chase Sun Pharmaceutical Co's Price-to-Operating-Cash-Flow Ratio for today is 7.43.

The historical rank and industry rank for Tianjin Chase Sun Pharmaceutical Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

SZSE:300026' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.61   Med: 47.19   Max: 186.57
Current: 7.45

During the past 13 years, Tianjin Chase Sun Pharmaceutical Co's highest Price-to-Operating-Cash-Flow Ratio was 186.57. The lowest was 6.61. And the median was 47.19.

SZSE:300026's Price-to-Operating-Cash-Flow is ranked better than
81.96% of 682 companies
in the Drug Manufacturers industry
Industry Median: 16.21 vs SZSE:300026: 7.45

Tianjin Chase Sun Pharmaceutical Co's Cash Flow from Operations per share for the three months ended in Mar. 2024 was ¥0.05. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.43.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Tianjin Chase Sun Pharmaceutical Co was 39.40% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 99.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 37.80% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 16.90% per year.

During the past 13 years, Tianjin Chase Sun Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 317.90% per year. The lowest was -35.90% per year. And the median was 38.10% per year.


Tianjin Chase Sun Pharmaceutical Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Tianjin Chase Sun Pharmaceutical Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Chase Sun Pharmaceutical Co Price-to-Operating-Cash-Flow Chart

Tianjin Chase Sun Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.80 70.46 59.77 22.63 8.27

Tianjin Chase Sun Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.26 17.77 9.46 8.27 9.05

Competitive Comparison of Tianjin Chase Sun Pharmaceutical Co's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Chase Sun Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Chase Sun Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Chase Sun Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Tianjin Chase Sun Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.



Tianjin Chase Sun Pharmaceutical Co Price-to-Operating-Cash-Flow Calculation

Tianjin Chase Sun Pharmaceutical Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=3.21/0.432
=7.43

Tianjin Chase Sun Pharmaceutical Co's Share Price of today is ¥3.21.
Tianjin Chase Sun Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.43.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Tianjin Chase Sun Pharmaceutical Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Tianjin Chase Sun Pharmaceutical Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Chase Sun Pharmaceutical Co (SZSE:300026) Business Description

Traded in Other Exchanges
N/A
Address
No. 20, Quanfa Road, Tianjin Wuqing Development Area, Tianjin, CHN, 301700
Tianjin Chase Sun Pharmaceutical Co Ltd is a high-tech medicine and health industry group. The company offers Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet-based therapy.
Executives
Yao Xiao Qing Director
Chen Rui Qiang Executives
Li Chun Xu Executives
Lan Wu Jun Directors, Directors, and Executives
Zheng Dan Directors, executives
Zhang Kun Executives
Gao Guo Wei Executives
Shang Xiao Mei Securities Affairs Representative
Sun Zhang Hai Director
Wu Guang Ning Supervisors
Wang Long Executives
Liu Qiang Supervisors
Ceng Guo Zhuang Director
Su Bing Jun Directors, executives
Nie Wei Supervisors

Tianjin Chase Sun Pharmaceutical Co (SZSE:300026) Headlines

No Headlines